Teladoc Health, Inc. filed 5 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-25. Between them they name 4 people, with 3 appointments and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Departing: Adam C. Vandervoort, Chief Legal Officer, effective 2026-11-01
On September 24, 2026, Mr. Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, Inc. (the "Company"), informed the Company of his decision to resign, effective November 1, 2026.
Appointed: Michael Grasher, Chief Financial Officer, effective 2026-08-31
Effective August 31, 2026, Teladoc Health, Inc. (the "Company") hired Michael Grasher as its Chief Financial Officer.
Reported
On August 10, 2026, Mr. David B. Snow, Jr. notified Teladoc Health, Inc. (the "Company") of his intention to retire from the Board effective as of September 30, 2026.
Appointed: Mark V. Anquillare, Director, effective 2026-08-03
Effective August 3, 2026, the Board of Directors (the "Board") of Teladoc Health, Inc. (the "Company") increased the number of directors on the Board to ten and appointed Mark V. Anquillare as a director of the Company.
Appointed: Susan R. Salka, Director, effective 2026-03-30
Effective March 30, 2026, the Board of Directors (the "Board") of Teladoc Health, Inc. (the "Company") increased the number of directors on the Board to nine and appointed Susan R. Salka as a director of the Company.
Find people with the same kind of experience as the Chief Legal Officer at Teladoc Health, Inc., with the record behind each one.
Find candidates like Chief Legal Officer at Teladoc Health, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Teladoc Health, Inc. is in the news or changes leadership.
Get an alert when Teladoc Health, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Teladoc Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.